Partnerships formed during the COVID-19 pandemic have provided a platform for change in assay development and transfers that should continue in the future.
Luc Gagnon
Advertisement
Luc Gagnon, PhD, is vice-president of Vaccine Sciences at Nexelis.
Articles by Luc Gagnon
Advertisement
Latest Updated Articles
The Key Elements for Assay Transfer SuccessDecember 2nd 2021
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Zumilokibart: Inside AbbVie's $10.9B Pipeline Bet
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
PharmTech Weekly Roundup—June 19, 2026
4
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
5